Aithal, G. P., Nicoletti, P., Bjornsson, E., Lucena, M. I., Andrade, R. J., Grove, J., … Daly, A. K. (2015). HLA-A*33:01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds. In HEPATOLOGY (Vol. 62, pp. 325A-326A). San Francisco, CA: WILEY-BLACKWELL.

Aithal, Guruprasad P., Paola Nicoletti, Einar Bjornsson, M. I. Lucena, Raul J. Andrade, Jane Grove, C. Stephens, et al. “HLA-A*33:01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds.” In HEPATOLOGY, 62:325A-326A. WILEY-BLACKWELL, 2015.

Aithal GP, Nicoletti P, Bjornsson E, Lucena MI, Andrade RJ, Grove J, et al. HLA-A*33:01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds. In: HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 325A-326A.

Aithal, Guruprasad P., et al. “HLA-A*33:01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds.” HEPATOLOGY, vol. 62, WILEY-BLACKWELL, 2015, pp. 325A-326A.

Aithal GP, Nicoletti P, Bjornsson E, Lucena MI, Andrade RJ, Grove J, Stephens C, Hallberg P, Maitland-van der Zee AH, Martin JH, Cascorbi I, Dillon JF, Laitinen T, Larrey DG, Molokhia M, Kullak-Ublick GA, Ibanez L, Pirmohamed M, Qin S, Sawle A, Bessone F, Hernandez N, Stolz A, Chalasani NP, Serrano J, Barnhart HX, Fontana RJ, Watkins P, Urban TJ, Daly AK. HLA-A*33:01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds. HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 325A-326A.